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What’s already know about this topic? 
• Sensitization is important in knee osteoarthritis, but high quality evidence on its treatment is 
missing 
What does this study add? 
• Knee replacement followed by non-surgical treatment is more effective in reducing 
sensitization, but not other pain-related measures, as compared to non-surgical treatment 
alone at 3 months. 
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ABSTRACT 
Background: The objective was to compare the effect of total knee replacement (TKR) followed 
by a 3-month non-surgical treatment with the non-surgical treatment alone in reducing pain 
sensitization and other pain-related measures in patients with knee osteoarthritis (OA).  
Methods: One hundred patients were randomized to 1) TKR followed by a non-surgical treatment 
of neuromuscular exercise, education, diet, insoles and pain medication or 2) the non-surgical 
treatment alone. Outcomes assessed at baseline and after 3 months were: 1) pain sensitization 
assessed as pressure pain thresholds (PPTs) at the knee (localized sensitization) and the lower leg 
(spreading sensitization), 2) peak pain intensity during the previous 24h, 3) pain intensity after 30 
min of walking, 4) pain location and pattern, 5) spreading of pain on a region-divided body chart, 
and 6) the usage of pain medication.  
Results: There was a statistical significant mean difference (95% CI) in change in PPTs from 
baseline to 3 months between groups in the crude analysis of 71 kPa (21-121) and of 75 kPa (33-
117) when adjusting for baseline PPT, age, gender and BMI, favoring the group having TKR. There 
were no significant between-group differences in change in the pain-related measures from baseline 
to 3 months (P = 0.15-0.27). Both groups improved in most of the pain-related measures (P < 0.05). 
Conclusions: At 3 months, TKR followed by non-surgical treatment is more effective in reducing 
localized and spreading pain sensitization than non-surgical treatment alone. Both treatments are 
equally efficacious in reducing the pain-related measures of this study.  
Trial registration: NCT01410409 
Keywords (4-6):  Knee; Osteoarthritis; Clinical trial; Pain; Sensitization 
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INTRODUCTION 
Pain is the hallmark symptom of knee osteoarthritis (OA) and is believed to be a complex 
phenomenon encompassing several mechanisms (Dieppe and Lohmander, 2005). Recently, 
sensitization has emerged as an important pain mechanism in knee OA, especially in patients with 
more advanced disease severity (Arendt-Nielsen and Graven-Nielsen, 2011,Arendt-Nielsen et al., 
2015b,Skou et al., 2014). The International Association for the Study of Pain (IASP) defines 
sensitization as increased responsiveness of nociceptive neurons to their normal input, and/or 
recruitment of a response to normally subthreshold inputs (International Association for the Study 
of Pain, ).  
Using a mechanism-based approach sensitization can be assessed in patients with knee OA applying 
quantitative sensory testing (QST) (Suokas et al., 2012), involving an assessment of the 
somatosensory response evoked from a controlled painful or non-painful stimuli (Graven-Nielsen 
and Arendt-Nielsen, 2010). Pressure algometry is one of the most widely used techniques for QST. 
Pressure pain sensitivity in patients (compared to pain free controls) demonstrated locally at the 
affected body part can be related to local and/or spreading sensitization (central sensitization) 
(Arendt-Nielsen and Graven-Nielsen, 2011,Graven-Nielsen and Arendt-Nielsen, 2010). Local and 
spreading sensitization have previously been demonstrated in patients with knee OA compared to 
pain-free controls (Arendt-Nielsen et al., 2010,Imamura et al., 2008,Lee et al., 2011,Graven-Nielsen 
et al., 2012,Kosek et al., 2013,Wylde et al., 2012).  
Previous studies assessing the effects of total knee replacement (TKR) on sensitization have 
demonstrated inconsistent results (Graven-Nielsen et al., 2012,Kosek et al., 2013) and have only 
been case series thereby being associated with potential bias (Moher et al., 2010). Furthermore, due 
to the complexity of pain, assessing the effects of TKR on other pain-related measures, such as pain 
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intensity, usage of pain medication, pain pattern and spreading of pain, could contribute with 
additional important information for future treatment of patients with knee OA. 
Recently, a high-quality randomized controlled trial (RCT) demonstrated that TKR followed by a 
non-surgical treatment program (exercise, education, weight loss, insoles and pain medication) 
resulted in greater improvements in pain, function and quality of life as compared to non-surgical 
treatment alone (Skou et al., 2015). In the RCT, other secondary outcomes were collected to allow 
for pre-specified ancillary analyses, including an analysis of the effects from the treatment on 
sensitization and pain (Skou et al., 2014). The aim of this pre-specified ancillary analysis from the 
RCT was to investigate the effects of TKR followed by the non-surgical treatment program in 
improving sensitization and other pain-related measures (pain intensity, pain location and pattern, 
spreading of pain and usage of pain medication) after 3 months compared to the non-surgical 
treatment alone. The hypothesis was that TKR followed by non-surgical treatment program would 
improve sensitization and pain more than non-surgical treatment program alone. 
 
METHODS 
Study design 
This was an ancillary analysis of the 3-month results from a two-arm parallel group assessor-
blinded RCT conforming to the CONSORT statement for reporting RCTs (Moher et al., 2010). The 
analysis was pre-defined in the statistical analysis plan, which was made available before any 
analyses commenced (Skou et al., 2014).  
Details of the study was published in the study protocol (Skou et al., 2012).  
Patients 
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One hundred patients with radiographic (Kellgren and Lawrence score ≥2) (Schiphof et al., 2011) 
and symptomatic knee OA found eligible for TKR by an orthopedic surgeon were enrolled. Patients 
were recruited from two specialized, public outpatient clinics at Aalborg University Hospital in 
Denmark (Frederikshavn and Farsoe, 50 patients from each clinic) between 12 September 2011 and 
6 December 2013. Major exclusion criteria were previous knee replacement on the same side; a 
need for bilateral simultaneous knee replacement; and a mean knee pain intensity in the previous 
above 60 mm on a 100 mm visual analogue scale (VAS).  
All patients gave informed consent before being enrolled, and the study was conducted in 
accordance with the Helsinki declaration and was approved by the local Ethics Committee of The 
North Denmark Region (N-20110024). Furthermore, it was registered at ClinicalTrials.gov 
(NCT01410409). 
Intervention 
Total knee replacement (TKR) 
Patients randomized to TKR followed by non-surgical treatment had a total cemented prosthesis 
with patellar resurfacing (NexGen, CR-Flex, fixed bearing or LPS-Flex, fixed bearing, Zimmer, 
Warsaw, Indiana, USA, applying standard methods (Endres, 2011). 
Non-surgical treatment 
Patients in both groups participated in the non-surgical treatment program at the same facility, but 
separately to avoid contamination and crossover between treatment groups. The 3-month non-
surgical treatment included a prescription of education, exercise and insoles to everyone in the 
MEDIC group, while weight loss and/or pain medication were prescribed if indicated. The 
treatments were given by physiotherapists and dieticians at Aalborg University Hospital, Denmark. 
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Education 
Two 60-min sessions actively engaging the patients and focusing on disease characteristics, OA 
pain and how to control and monitor it during exercise, treatment and help to self-help.  
Exercise 
The NEuroMuscular EXercise training program (NEMEX), previously found feasible in patients 
waitlisted for TKR (Ageberg et al., 2010b), was delivered twice weekly with each session lasting 60 
min. The program is based on neuromuscular and biomechanical principles and has different levels 
of difficulty for each exercise (Ageberg et al., 2010b). The exercise program was followed by a 
transition period of 8 weeks to gradually accustom patients to continue exercising at home.  
Dietary advice 
Patients who had a body mass index (BMI) ≥25 at baseline underwent a dietary weight loss 
program based on principles from motivational interviewing (Miller and Rollnick, 2002), consisting 
of four 60-min sessions, with the aim of reducing body weight by at least 5% (Christensen et al., 
2007).  
Insoles 
The patients received individually fitted full-length Formthotics Original Dual Medium (perforated) 
insoles with medial arch support (Foot Science International, Christchurch, New Zealand). A 4° 
lateral wedge was added to the insoles of patients with a knee-lateral-to-foot position (the knee 
moves over or lateral to the 5th toe in three or more of five trials) tested with the valid and reliable 
Single Limb Mini Squat Test (Ageberg et al., 2010a).  
Pain medication 
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If indicated, paracetamol 1 g four times daily, ibuprofen 400 mg three times daily, and pantoprazole 
20 mg daily were prescribed. The prescription was reassessed every 3 weeks to supervise the use 
and indications of the medication.  
Outcomes 
Baseline and 3-month follow-up were carried out at the Department of Occupational Therapy and 
Physiotherapy, Aalborg University Hospital, Denmark. The assessor was unaffiliated with the 
treatment sites, and specifically trained in all aspects of the assessments. The assessor was blinded 
to treatment allocation by instructing patients to cover the study knee with three layers of white 
elastic tape covering a potential scar after TKR surgery before meeting the assessor. 
Assessment of sensitization 
Bilateral, pressure pain thresholds (PPTs) were obtained using a handheld algometer with a 1 cm2 
probe (Algometer Type II, Somedic AB, Hoerby, Sweden). Applied perpendicular to the skin at a 
constant rate of 30 kPa/s, pressure was increased until the patient felt the pressure change to pain 
and pressed a button defining the PPT. To ensure that the patient understood the procedure, one or 
two test assessments were performed at the dorsal aspect of the hand. A previous assessment of the 
test procedure in a test-retest reliability and agreement study with 20 patients with knee OA 
demonstrated intraclass correlation coefficients (2-way random-effects model, consistency-type) 
and 95 % limits of agreement (95% LOA; presented as the difference between the mean difference 
and the upper and lower LOA) ranging from 0.84 to 0.91 and 199.6 to 434.0 kPa for the different 
sites (Skou et al., 2015). The 95% LOA corresponds to the minimal detectable change (MDC) for 
the assessment method. 
Localized sensitization 
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PPTs from four sites at the knee, all in proximity to the patella were used to assess localized 
sensitization (peripheral sensitization): (1) 3 cm medial to the midpoint of the medial edge, (2) 2 cm 
proximal to the midpoint of the superior edge, (3) 3 cm lateral to the midpoint of the lateral, and (4) 
at the center (Arendt-Nielsen et al., 2010). PPTs were obtained twice at each site, and the mean of 
all four sites was used in the analyses. 
Spreading sensitization 
PPTs from the tibialis anterior muscle (lower leg: 5 cm distal to the tibial tuberosity) was used to 
assess spreading sensitization (central sensitization) (Arendt-Nielsen et al., 2010). PPTs were 
obtained twice and the mean was used in the analyses. 
Assessment of pain 
Peak pain intensity in the most affected knee during the previous 24 h was assessed on a 100 mm 
VAS with terminal descriptors of ‘no pain’ and ‘worst pain possible’ was chosen based on its 
frequent application in studies on sensitization in knee OA-related pain (Skou et al., 2014,Arendt-
Nielsen et al., 2010,Skou et al., 2013). The VAS is a measure of pain widely used in patients with 
knee OA that is valid, reliable and responsive (Hawker et al., 2011).  
Pain intensity during function 
Knee pain intensity after 30 min of walking was assessed on a 100-mm VAS with terminal 
descriptors of ‘no pain’ and ‘worst pain possible’ was chosen, since it can serve as an indirect 
measure of how knee pain affects function.  
Knee pain location and pattern 
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Using the reliable interviewer-administered questionnaire Knee Pain Map, previously applied in 
patients with knee OA (Thompson et al., 2009,Thompson et al., 2010), knee pain location and 
pattern in the most affected knee were assessed. The Knee Pain Map identifies areas of the knee, 
which are painful, and characterizes the pain as localized, regional or diffuse (Thompson et al., 
2009,Thompson et al., 2010). Diffuse pain is indicative of a more progressed sensitization (Arendt-
Nielsen and Graven-Nielsen, 2011), which is why pain location and pattern were dichotomized 
(yes/no to diffuse pain in the most affected knee).  
Spreading of pain 
The patients shaded body sites with pain in the previous 24 hours on a region-divided body chart 
(26 sites in total). The total number of pain sites was used to quantify the spreading of pain (Coggon 
et al., 2013).  
Usage of pain medication 
Defined as any pain medication taken on a regular basis during the last week at baseline and at the 
3-month follow-up. Due to non-uniformity of the distribution of pain medication intake, the results 
were dichotomized (yes/no to pain medication).  
Statistical analysis 
Sample size 
The sample size was powered for the primary RCT, based on the primary outcome the Knee injury 
and Osteoarthritis Outcome Score (KOOS)4, with scores ranging from 0 (worst) to 100 (best). 
KOOS4 is the mean score for the KOOS subscale scores for Pain, Symptoms, Function, daily living 
and Quality of life (Roos et al., 1998,Roos and Toksvig-Larsen, 2003). The sample size needed to 
detect a 10 point difference (SD 14) between groups in KOOS4 was 41 patients in each group 
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(power of 90 % and a significance level at 0.05 (2-sided)). To account for crossovers to TKR from 
the non-surgical treatment only group, and for missing data, the dropout rate was set to 20%, and a 
total of 100 patients were randomized. In this pre-specified ancillary analysis we were interested in 
exploring the effects of TKR followed by non-surgical treatment or non-surgical treatment alone on 
sensitization and pain.  
 Ancillary analyses 
Since this was an ancillary analysis, only patients staying in the group that they were randomized to 
during the 3-month follow-up with available data from both the baseline and 3-month follow-up 
were included in the analyses. As endorsed by The European Agency for the Evaluation of 
Medicinal Products when ancillary analyses are declared as supportive, no adjustments for 
multiplicity were done (The European Agency for the Evaluation of Medicinal Products, CPMP, 
2002).  
To evaluate change in pain intensity and number of pain sites between and within groups a 
Student’s t-test was applied. A 3-way analysis of variance (ANOVA) was used to evaluate change 
in PPT from baseline to 3 months using the fixed factors group (TKR + non-surgical, non-surgical), 
site (knee, lower leg) and side (most affected, contralateral). The analysis was conducted both 
unadjusted and adjusted (baseline PPT, gender, age and BMI). Within-group changes in PPTs due 
to the treatment were further assessed using a repeated measures ANOVA with time (baseline, 3 
months), site (knee, lower leg) and side (most affected, contralateral) as the within-subject factors 
for both the TKR + non-surgical group and the non-surgical group. The assumption of homogeneity 
of variance was tested using Levene’s test (P > 0.05), and the assumption of normal distribution 
was tested by visual inspection of Q-Q plots. Tukey-Kramer was used as a post hoc test if ANOVA 
factors or interactions were significant.  
12 
 
The relative risks for usage of pain medication and diffuse pain were estimated and compared 
between groups using a Poisson regression model with a robust error variance for the confidence 
intervals. 
All analyses were performed in either IBM SPSS Statistics (Version 22, IBM Corporation, Armonk, 
NY, USA) or Stata 13 (StataCorp, College Station, TX, USA). The significance level was set at P < 
0.05. 
 
RESULTS 
In all, 1,470 patients seen in secondary care by an orthopedic surgeon were assessed for eligibility, 
1,348 were ineligible, and 27 did not want to participate. The primary reasons for ineligibility were 
being ineligible for a TKR (n = 544), OA not severe enough (Kellgren-Lawrence score < 2; n = 
197), not able to participate in intervention (n=180), and unable to come to treatment site (n=145). 
One hundred patients were randomized, with 41/50 (82%; one patient did not undergo TKR) in the 
TKR + non-surgical group and 46/50 (92%; one patient underwent TKR during the 3 months) in the 
non-surgical group completing both baseline and 3-month follow-up. For further information on the 
study flow (including Flow diagram), please refer to (Skou et al., 2015). Patient characteristics are 
presented in Table 1 and pain location and pattern at baseline are presented in Table 2. 
Between-group analyses 
Localized and spreading sensitization 
There was a statistically significant mean difference (95% CI) in change in PPTs from baseline to 3 
months between groups in the crude analysis of 71 kPa (21-121), F(1,304) = 7.897, P = 0.005 (Fig. 
1). The difference remained significant when adjusting for baseline PPT, age, gender and BMI with 
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a mean difference (95% CI) of 75 kPa (33-117), F(1,300) = 12.091, P = 0.001. Both the crude and 
adjusted analysis favored the TKR + non-surgical group. Neither site nor side had a statistically 
significant effect on the results. 
Peak pain intensity 
The difference in change (95 % CI) from baseline to 3 months of 7.9 (-6.1 to 21.0) millimeter in 
peak pain intensity in favor of the TKR + non-surgical group was not statistically significant (P = 
0.27).  
Pain intensity during function 
The difference in change (95 % CI) from baseline to 3 months of 9.5 (-5.1 to 24.1) millimeter in 
pain intensity during function in favor of the TKR + non-surgical group was not statistically 
significant (P = 0.20). 
Knee pain location and pattern 
There was no significant difference between groups in the number of patients with diffuse pain at 3 
months compared to baseline (Table 3).  
Spreading of pain 
The difference in change (95 % CI) from baseline to 3 months of 0.7 (-0.3 to 1.8) in the number of 
body sites with pain in favor of the TKR + non-surgical group was not statistically significant (P = 
0.15). 
Fig. 2 illustrates the difference in body sites with pain at baseline and after 3 months in the TKR + 
non-surgical group and the non-surgical group.  
Usage of pain medication 
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There was no significant difference between groups in the usage of pain medication at 3 months 
compared to baseline (Table 4).  
 
Within-group analyses 
Within-group results are presented in Tables 3–5. 
 
DISCUSSION 
The present study showed that TKR followed by a 3-month non-surgical treatment program was 
associated with greater improvements in localized and spreading sensitization, but not pain 
intensity, pain location and pattern, spreading of pain and usage of pain medication after 3 months 
as compared to non-surgical treatment alone. Due to the exploratory nature of the analysis, the 
results must be interpreted with caution. 
The two previous non-randomized reports on the effects of TKR on sensitization had conflicting 
result (Graven-Nielsen et al., 2012,Kosek et al., 2013). While Graven-Nielsen et al. demonstrated a 
normalization of a range of measures of sensitization (Graven-Nielsen et al., 2012), including PPTs 
from the lower leg of the operated and non-operated leg, Kosek et al. found no effects of TKR on 
PPTs from a range of body sites, including the knee of the operated and non-operated leg (Kosek et 
al., 2013). The present high-quality RCT extends the findings from Graven-Nielsen et al. (Graven-
Nielsen et al., 2012) with improvements in PPTs from the knee and lower leg of the operated and 
non-operated leg of patients with knee OA undergoing TKR followed by non-surgical treatment 
when compared to patients undergoing non-surgical treatment alone. A previous RCT in patients 
with knee OA not eligible for TKR demonstrated that even though PPTs from the knee, lower leg 
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and arm improved from the same non-surgical treatment as in this trial, the improvements were not 
larger than those seen in patients receiving information and advice on treatment only (Skou et al., 
2016). In the present trial, patients randomized to non-surgical treatment alone did not improve in 
sensitization. It is possible that the conflicting results could be caused by a type II error, since this 
study was not powered to detect this difference. However, since the group randomized to TKR 
followed by non-surgical treatment improved, it seems reasonable that the type, and perhaps the 
invasiveness, of the treatment plays an important role when it comes to improving sensitization. 
TKR is a major surgery involving replacement of joint surfaces of the affected knee (Carr et al., 
2012), which are likely to cause major changes in the environment of the joint, potentially being of 
a sufficient dose to reduce sensitization in knee OA. Future confirmatory trials and studies looking 
at mechanisms behind this change are needed. 
The primary report from this RCT demonstrated that, albeit associated with more serious adverse 
events, TKR followed by non-surgical treatment reduced pain during activities with 17.1 units more 
that non-surgical treatment alone on a 0-100 scale (Skou et al., 2015). Both treatment groups of the 
trial had clinically relevant improvements in pain at 12-month follow-up (Skou et al., 2015) and this 
study confirms the difference between groups being initiated already at 3 months. However, the 
difference in change between groups at 3 months was not significant for any of the pain-related 
measures (risk of type II error). Since pain has the potential to improve for at least 12 months after 
TKR (Nilsdotter et al., 2009), the full effects from the surgery are not manifested after 3 months 
potentially explaining the non-significant findings. In addition many different pain mechanisms and 
sensitization process are involved in painful end-stage OA (Arendt-Nielsen et al., 2015b,Arendt-
Nielsen et al., 2015a,Egsgaard et al., 2015) and hence a variety of mechanistic pain assessment tools 
are needed to tease out the contribution of the various mechanisms (Arendt-Nielsen et al., 
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2015b,Skou et al., 2014,Skou et al., 2013,Arendt-Nielsen et al., 2015a,Egsgaard et al., 
2015,Dworkin et al., 2005).   
The present study has some limitations. First of all, it is important to acknowledge, that since the 
sample size was powered based on the primary RCT, the non-significant findings of this analysis 
could merely be a result of a type II error. Furthermore, since the non-surgical treatment consisted 
of several non-surgical treatments that were delivered in an individualized fashion with regards to 
specific content and intensity, there could have been systematic differences between groups. We did 
not adjust for all potential confounders in the analysis of PPTs. As recommended by the European 
Medicines Agency we decided to include only a few of the most important covariates, including the 
baseline PPT (The European Medicines Agency, 2015). Additionally, the multimodal nature of the 
non-surgical treatment, preclude the possibility to differentiate the effects of the individual 
treatment modalities. However, as the intervention was standardized and delivered by the same 
physiotherapists and dieticians, and as the multimodal approach individualized to patient is 
recommended in clinical guidelines on the treatment of knee OA (Fernandes et al., 2013,McAlindon 
et al., 2014), the generalizability of the results is strengthened. 
Conclusions 
TKR followed by a non-surgical treatment program is more effective in reducing localized and 
spreading sensitization, but not other pain-related measures, as compared to the non-surgical 
program alone in patients with knee OA. Both treatment options demonstrated clinically relevant 
changes in pain-related measures, highlighting their applicability in clinical practice. 
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FIGURE LEGENDS 
Figure 1. Pressure pain thresholds on the most affected side. Mean pressure pain thresholds 
(PPT) measured in kPa using a handheld algometer on the knee and lower leg. The TKR + non-
surgical group had significantly larger improvements in pressure pain thresholds from baseline to 3 
months compared to the non-surgical group (P < 0.05). Furthermore, while the TKR + non-surgical 
group had significantly higher PPTs (*; P < 0.05) after 3 months compared to baseline the non-
surgical had not. Error bars indicate 95% confidence intervals.  
 
Figure 2. Pain sites. Sites of the body where at least 10% of the patients in the TKR + non-surgical 
group (A) and in the non-surgical group (B) reported pain during the previous 24 hours. A black 
shade indicates that at least 10% reported pain at both baseline and at the 3-month follow-up, while 
a grey shade indicates that at least 10% reported pain at baseline, but not at the 3-month follow-up. 
The right side of the body in the figures has been set as the side mostly affected by knee 
osteoarthritis. Less than 10% in the TKR + non-surgical group had pain in the foot of the most 
affected leg at baseline, while 10% had it at 3-month follow-up. 
 
